| Primary |
| Tuberculosis |
29.5% |
| Drug Use For Unknown Indication |
25.1% |
| Pulmonary Tuberculosis |
10.3% |
| Hiv Infection |
10.0% |
| Product Used For Unknown Indication |
5.5% |
| Bone Tuberculosis |
2.2% |
| Prophylaxis |
2.2% |
| Cholecystectomy |
1.5% |
| Delirium |
1.5% |
| Epilepsy |
1.5% |
| Gout |
1.5% |
| Lymph Node Tuberculosis |
1.5% |
| Tuberculous Pleurisy |
1.5% |
| Ganglionic Tuberculosis |
1.1% |
| Granuloma |
1.1% |
| Irritable Bowel Syndrome |
1.1% |
| Gastric Tube Reconstruction |
0.7% |
| Hyperuricaemia |
0.7% |
| Meningitis |
0.7% |
| Pain |
0.7% |
|
| Rash |
14.0% |
| Lymphadenopathy |
9.3% |
| Vomiting |
9.3% |
| Stevens-johnson Syndrome |
7.0% |
| Thrombocytopenia |
7.0% |
| Hepatocellular Injury |
4.7% |
| Hyperthermia |
4.7% |
| Periarthritis |
4.7% |
| Pyrexia |
4.7% |
| Rash Maculo-papular |
4.7% |
| Renal Failure Acute |
4.7% |
| Toxic Skin Eruption |
4.7% |
| Tuberculosis |
4.7% |
| Abdominal Pain |
2.3% |
| Acute Generalised Exanthematous Pustulosis |
2.3% |
| Agranulocytosis |
2.3% |
| Anxiety |
2.3% |
| Completed Suicide |
2.3% |
| Dermatitis Exfoliative |
2.3% |
| Drug Exposure During Pregnancy |
2.3% |
|
| Secondary |
| Tuberculosis |
27.5% |
| Hiv Infection |
20.2% |
| Drug Use For Unknown Indication |
12.5% |
| Pulmonary Tuberculosis |
6.3% |
| Hodgkin's Disease |
4.1% |
| Prophylaxis |
3.8% |
| Lymph Node Tuberculosis |
3.1% |
| Product Used For Unknown Indication |
3.0% |
| Hiv Test Positive |
2.8% |
| Anaemia |
2.5% |
| Ankylosing Spondylitis |
2.3% |
| Bone Tuberculosis |
1.9% |
| Antifungal Prophylaxis |
1.7% |
| Unevaluable Event |
1.4% |
| Antiretroviral Therapy |
1.3% |
| Diarrhoea |
1.3% |
| Hypertension |
1.3% |
| Asthma |
1.1% |
| Cytomegalovirus Infection |
1.1% |
| Diabetes Mellitus |
1.1% |
|
| Renal Failure |
10.3% |
| Vomiting |
10.3% |
| Renal Failure Acute |
9.3% |
| Neuropathy Peripheral |
8.2% |
| Pyrexia |
8.2% |
| Lymphadenopathy |
6.2% |
| Impaired Gastric Emptying |
5.2% |
| Tuberculosis |
5.2% |
| Weight Decreased |
5.2% |
| Agranulocytosis |
4.1% |
| Cholestasis |
4.1% |
| Drug Ineffective |
4.1% |
| Oedema Peripheral |
3.1% |
| Tongue Haemorrhage |
3.1% |
| Transaminases Increased |
3.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.1% |
| Hepatitis |
2.1% |
| Hepatomegaly |
2.1% |
| Immune Reconstitution Syndrome |
2.1% |
| Liver Function Test Abnormal |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
18.9% |
| Tuberculosis |
18.0% |
| Hiv Infection |
17.0% |
| Product Used For Unknown Indication |
13.0% |
| Mycobacterial Infection |
5.1% |
| Pulmonary Tuberculosis |
4.4% |
| Rheumatoid Arthritis |
4.2% |
| Prophylaxis |
3.5% |
| Antifungal Prophylaxis |
2.9% |
| Pain |
2.2% |
| Ill-defined Disorder |
1.6% |
| Depression |
1.5% |
| Central Nervous System Lesion |
1.2% |
| Lymph Node Tuberculosis |
1.2% |
| Hepatitis C |
1.0% |
| Ankylosing Spondylitis |
0.9% |
| Antiviral Prophylaxis |
0.9% |
| Cytomegalovirus Infection |
0.9% |
| Diarrhoea |
0.9% |
| Hypertension |
0.9% |
|
| Vomiting |
15.6% |
| Immune Reconstitution Syndrome |
8.9% |
| Neutropenia |
8.9% |
| Pyrexia |
6.7% |
| Renal Failure |
6.7% |
| Systemic Inflammatory Response Syndrome |
5.6% |
| Tubulointerstitial Nephritis |
5.6% |
| Weight Decreased |
5.6% |
| Whipple's Disease |
5.6% |
| Tuberculosis |
4.4% |
| Aplasia Pure Red Cell |
3.3% |
| Lymphadenitis |
3.3% |
| Mixed Liver Injury |
3.3% |
| Stillbirth |
3.3% |
| Acute Generalised Exanthematous Pustulosis |
2.2% |
| Acute Respiratory Distress Syndrome |
2.2% |
| Gamma-glutamyltransferase Increased |
2.2% |
| Hyperthyroidism |
2.2% |
| Interstitial Lung Disease |
2.2% |
| Lymphadenopathy |
2.2% |
|
| Interacting |
| Lennox-gastaut Syndrome |
62.5% |
| Pulmonary Tuberculosis |
37.5% |
|
| Somnolence |
50.0% |
| Unintended Pregnancy |
50.0% |
|
